Rapid Micro Biosystems (NASDAQ:RPID) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.01), Zacks reports. Rapid Micro Biosystems had a negative return on equity of 177.04% and a negative net margin of 145.56%. The company had revenue of $9.53 million during the quarter, compared to analysts’ expectations of $9.85 million.

Rapid Micro Biosystems Stock Performance

Shares of Rapid Micro Biosystems stock opened at $0.74 on Tuesday. The company has a current ratio of 2.55, a quick ratio of 1.51 and a debt-to-equity ratio of 1.08. The stock’s fifty day moving average price is $0.91 and its 200-day moving average price is $2.06. The firm has a market cap of $37.12 million, a P/E ratio of -0.66 and a beta of 1.52. Rapid Micro Biosystems has a 12 month low of $0.58 and a 12 month high of $4.94.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Thursday, October 15th. Lake Street Capital downgraded shares of Rapid Micro Biosystems from a “buy” rating to a “hold” rating and set a $0.75 target price on the stock. in a research note on Monday. JPMorgan Chase & Co. set a $0.75 target price on shares of Rapid Micro Biosystems in a research report on Tuesday. Finally, Roth Capital downgraded shares of Rapid Micro Biosystems from a “buy” rating to a “neutral” rating and decreased their price target for the company from $3.00 to $0.75 in a research note on Tuesday. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $1.81.

Check Out Our Latest Stock Report on RPID

Trending Headlines about Rapid Micro Biosystems

These are some of the RPID headlines that stood out recently:

About Rapid Micro Biosystems

(Get Free Report)

Rapid Micro Biosystems develops automated microbial detection systems for pharmaceutical, biotechnology and other life sciences manufacturers. Its products are designed to support quality-control testing by identifying and measuring microbial growth in manufacturing environments and products. The company’s Growth Direct platform combines laboratory instruments, consumables and software to automate microbial testing. Its applications include sterility testing, bioburden testing and environmental monitoring, helping manufacturers assess contamination during production.

Read More

Earnings History for Rapid Micro Biosystems (NASDAQ:RPID)

Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.